The AMYPAD consortium was a combination of 9 academic partners, 3 industrial partners, 2 SMEs and 1 patient organisation. AMYPAD has addressed its goals in close collaboration with IMI project EPAD in a public-private partnership. In addition, regular interactions and synergies with external experts and complementary initiatives have been established, fostering the attainment of the AMYPAD project objectives.
Download a complete list of AMYPAD investigators here. This document will be updated regularly to reflect the latest composition of the AMYPAD consortium who contributes to the design and implementation of the AMYPAD project and/or provides data.
VU University Medical Center Amsterdam (VUmc)
The University of Edinburgh (UEDIN)
Barcelona Beta Brain Research Center (BBRC)
University of Geneva (UNIGE)
Karolinska Institutet (KI)
IXICO Technologies Ltd (IXICO)
Hôpitaux de Toulouse (CHUT)
University College London (UCL)
Alzheimer Europe (AE)
Synapse Research Management Partners S.L (SYNAPSE)
University of Cologne (UKK)
GE Healthcare Worldwide (GE)
Janssen Pharmaceutica NV (JPNV)
Life Molecular Imaging (LMI)
Radboud University Medical Center (RUMC)
University of Geneva (UNIGE) - DPMS & PNHS
VU University Medical Center Amsterdam (VUmc) - DPMS & PNHS
Barcelona Beta Brain Research Center (BBRC) - DPMS & PNHS
Hôpitaux de Toulouse (CHUT) - DPMS & PNHS
University College London (UCL) - DPMS
University of Cologne (UKK) - DPMS
Karolinska Institutet (KI) - DPMS & PNHS
The University of Edinburgh (UEDIN) - PNHS
Lausanne University Hospital (CHUV) - DPMS
Centre Hospitalier Universitaire de Montpellier - PNHS
NHS Tayside - PNHS
Hôpitaux Universitaires Pitié Salpêtrière - PNHS
UZ Leuven - PNHS
Hôpital Lariboisière (Paris Nord) - PNHS
CHU Nantes - PNHS
Fundación CITA Alzheimer - PNHS
Alzheimer's Disease Data Initiative (ADDI)
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Organising Knowledge about Neurodegenerative Disease Mechanisms for the Improvement of Drug Development and Therapy (AETIONOMY)
ALFA
Dementias Platform UK (DPUK)
German Center for Neurodegenerative Diseases (DZNE)
European Medical Information Framework (EMIF)
European Prevention of Alzheimer’s Dementia Consortium (EPAD)
Fundació ACE Healthy Brain Initiative (FACEHBI)
Efficiently Networking European Neurodegeneration Research (NEURONET)
Real world outcomes across the Alzheimer’s disease spectrum for better care: multi-modal data access platform (ROADMAP)
Twin study